Conmed (CNMD) Other Accumulated Expenses (2010 - 2026)

Conmed's Other Accumulated Expenses history runs 17 years deep, the most recent figure standing at $125.7 million for Q1 2026.

• Quarterly Other Accumulated Expenses fell 2.56% year-over-year to $125.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $125.7 million (down 2.56% YoY) and the FY2025 annual result came in at $138.5 million, up 26.18% from the prior year.
• Other Accumulated Expenses was $125.7 million for Q1 2026 at Conmed, down from $138.5 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $163.5 million in Q3 2023 and bottomed at $62.5 million in Q1 2022.
• A 5-year average of $119.4 million and a median of $125.1 million in 2025 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses surged 104.31% — and 2024, when it retreated 29.29%.
• Conmed's Other Accumulated Expenses stood at $98.7 million in 2022, then jumped by 53.76% to $151.7 million in 2023, then slipped by 27.63% to $109.8 million in 2024, then advanced by 26.18% to $138.5 million in 2025, then declined by 9.27% to $125.7 million in 2026.
• Business Quant data shows CNMD's Other Accumulated Expenses at $125.7 million in Q1 2026, $138.5 million in Q4 2025, and $130.7 million in Q3 2025.